Health issues and the environment - An emerging paradigm for providers of obstetrical and gynaecological health care

Human Reproduction

Volumn 21, Issue 9, 2006, Pages 2201-2208

  Genuis, Stephen J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Congenital anomalies; Endocrine disrupting chemicals; Environmental health; Human exposure assessment; Toxicology

Indexed keywords

ALCOHOL; COCAINE; DIETHYLSTILBESTROL; DIOXIN; ENDOCRINE DISRUPTOR; MERCURY; THALIDOMIDE; TOXIN;

ATTITUDE TO HEALTH; CANCER; CONGENITAL MALFORMATION; DRUG SAFETY; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; FETAL ALCOHOL SYNDROME; FETOTOXICITY; GYNECOLOGIC DISEASE; GYNECOLOGY; HEALTH CARE DELIVERY; HEALTH PRACTITIONER; HEALTH SERVICES RESEARCH; HUMAN; HYPEREMESIS GRAVIDARUM; MATERNAL CARE; MENTAL DISEASE; OBSTETRICS; PATIENT CARE; PATIENT COUNSELING; REPRODUCTIVE HEALTH; SHORT SURVEY; SKILL; SPONTANEOUS ABORTION; WOMEN'S HEALTH;

EID: 33749572441     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del181     Document Type: Short Survey

References (100)

1. Alonso-Magdalena P, Morimoto S, Ripoll C and Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114,106-112.
2. American Academy of Pediatrics Committee on Environmental Hazards and Committee on Accident and Poison Prevention (1987) Statement on childhood lead poisoning. Pediatrics 79,457-465.
3. Anway MD, Cupp AS, Uzumcu M and Skinner MK (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308,1466-1469.
4. Arias E, MacDorman MF, Strobino DM and Guyer B (2003) Annual summary of vital statistics - 2002. Pediatrics 112,1215-1230.
5. Baccarelli A, Mocarelli P, Patterson DG Jr, Bonzini M, Pesatori AE, Caporaso N and Landi MT (2002) Immunologic effects of dioxin: New results from Seveso and comparison with other studies. Environ Health Perspect 110,1169-1173.
6. Baker SM (1997) Detoxification and Healing: The Key to Optimal Health. Keats Publishing, New Canaan, CT.
7. Barton HA, Cogliano VJ, Flowers L, Valcovic L, Setzer RW and Woodruff TJ (2005) Assessing susceptibility from early-life exposure to carcinogens. Environ Health Perspect 113,1125-1233.
8. Berkson DL (2000) Hormone Deception: How Everyday Foods and Products are Disrupting Your Hormones. Contemporary Publishing Group, Chicago, IL.
9. Birnbaum LS (2005) The impact of early environmental chemical exposure on carcinogenesis. Presentation at Cancer and the Environment Conference, Tucson, AZ, 27-30 October 2005.
10. Birnbaum LS and Fenton SE (2003) Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 111,389-394.
11. Boyle CA, Decoufle P and Yeargin-Allsopp M (1994) Prevalence and health impact of developmental disabilities in US children. Pediatrics 93,399-403.
12. Branum AM, Collman GW, Correa A, Keim SE, Kessel W, Kimmel CA, Kebenoff MA, Longnecker MP, Mendola P, Rigas M et al. (2003) The National Children's Study of environmental effects on child health and development. Environ Health Perspect 111,642-646.
13. Brevini TA, Zanetto SB and Cillo F (2005) Effects of endocrine disruptors on developmental and reproductive functions. Curr Drug Targets Immune Endocr Metabol Disord 5,1-10.
14. Carpenter DO (1998) Polychlorinated biphenyls and human health. Int J Occup Med Environ Health 11,291-303.
15. Centers for Disease Control and Prevention: Department of Health and Human Services Third National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 05-0570, Atlanta, GA, July 2005, 1-475.
16. Claman P (2004) Men at risk: Occupation and male infertility. Sex Reprod Menopause 2004 2,19-26.
17. Cohn D (2002) Disability rate of children, teens up sharply - to 1 in 12. The Washington Post, July 6.
18. Colborn T, vom Saal FS and Soto AM (1993) Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101,378-384.
19. Collaer ML and Hines M (1995) Human behavioral sex differences: A role for gonadal hormones during early development? Psychol Bull 118,55-107.
20. Cordain L, Eades MR and Eades MD (2003) Hyperinsulinemic diseases of civilization: More than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol 136,95-112.
21. Cotton P (1994) Environmental estrogenic agents area of concern. JAMA 271,414, 416.
22. Cummings AM, Metcalf JL and Birnbaum L (1996) Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: Time-dose dependence and species comparison. Toxicol Appl Pharmacol 138,131-139.
23. Drbohlav P, Bencko V, Masata J and Jirsova S (2004) Effect of toxic substances in the environment on reproduction. Ceska Gynekol 69,20-26.
24. Dubeyl RK, Rosselli M, Imthurn B, Keller PJ and Jackson EK (2000) Vascular effects of environmental oestrogens: Implications for reproductive and vascular health. Hum Reprod Update 6,351-363.
25. Egeland GM, Sweeney MH, Fingerhut MA, Wille KK, Schnorr TM and Halperin WE (1994) Total serum testosterone and gonadotropins in workers exposed to dioxin. Am J Epidemiol 139,272-281.
26. Ehrhardt AA, Meyer-Bahlburg HFL, Rosen LR, Feldman JF, Veridiano NP, Zimmerman I and McEwen BS (1985) Sexual orientation after prenatal exposure to exogenous estrogen. Arch Sex Behav 14,57-77.
27. Ekbom A, Richiardi L, Akre O, Montgomery SM and Sparen P (2003) Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95,1238-1240.
28. Environmental Working Group (2005) Body burden - the pollution in newborns: A benchmark investigation of industrial chemicals, pollutants and pesticides in umbilical cord blood, (Executive Summary) 14 July 2005 (accessed 16 September 2005) (http://ewg.org/reports/bodyburden2/ execsumm.php).
29. Falsetti L and Eleftheriou G (1996) Hyperinsulinemia in the polycystic ovary syndrome: A clinical, endocrine and echographic study in 240 patients. Gynecol Endocrinol 10,319-326.
30. Forawi HA, Tchounwou PB and McMurray RW (2004) Xenoestrogen modulation of the immune system: Effects of dichlorodiphenyltrichloroethane (DDT) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Rev Environ Health 19,1-13.
31. Fraser-Moodie A (2003) Mad as a hatter. Emerg Med J 20,568.
32. Genuis SJ (2005) Nutritional transition: A determinant of global health. J Epidemiol Community Health 59,615-617.
33. Gilbertson M (2004) Male cerebral palsy hospitalization as a potential indicator of neurological effects of methylmercury exposure in Great Lakes communities. Environ Res 95,375-384.
34. Gorell JM, Johnson CC, Rybicki BA, Peterson EL and Richardson RJ (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50,1346-1350.
35. Greenlee AR, Arbuckle TE and Chyou PH (2003) Risk factors for female infertility in an agricultural region. Epidemiology 14,429-436.
36. Harte J, Holdren C, Schneider R et al. (1991) Toxics A to Z: A Guide to Everyday Pollution Hazards. University of California Press, Berkeley, CA.
37. Hauser R, Williams P, Altshul L and Calafat AM (2005) Evidence of interaction between polychlorinated biphenyls and phthalates in relation to human sperm motility. Environ Health Perspect 113,425-430.
38. Heilier JF, Nackers F, Verougstraete V, Tonglet R, Lison D and Donnez J (2005) Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 84,305-312.
39. Khattak S, Moghtader GK, McMartin K, Barrera M, Kennedy D and Koren G (1999) Pregnancy outcome following gestational exposure to organic solvents: A prospective controlled study. JAMA 281,1106-1109.
40. Kilburn KH (1998) Chemical Brain Injury. John Wiley and Sons, New York.
41. Kilburn KH (2004) Endangered Brains: How Chemicals Threaten Our Future. Princeton Scientific Publishers, Birmingham.
42. Kilburn KH, Warsaw RH and Shields MG (1989) Neurobehavioral dysfunction in firemen exposed to polychlorinated biphenyls (PCBs): Possible improvement after detoxification. Arch Environ Health 44,345-350.
43. Kilpatrick N, Frumkin H, Trowbridge J, Escoffery C, Geller R, Rubin L, Teague G and Nodvin J (2002) The environmental history in pediatric practice: A study of pediatricians' attitudes, beliefs, and practices. Environ Health Perspect 110,823-827.
44. Knox EG (2005) Childhood cancers and atmospheric carcinogens. J Epidemiol Community Health 59,101-105.
45. Koninckx PR (1999) The physiopathology of endometriosis: Pollution and dioxin. Gynecol Obstet Invest 47(Suppl 1),47-49.
46. Koninckx PR, Braet P, Kennedy SH and Barlow DH (1994) Dioxin pollution and endometriosis in Belgium. Hum Reprod 9,1001-1002.
47. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F and Mazzeo P (2003) In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 111,1783-1785.
48. Louis GM, Weiner JM, Whitcomb BW, Sperrazza R, Schisterman EF, Lobdell DT, Crickard K, Greizerstein H and Kostyniak PJ (2005) Environmental PCB exposure and risk of endometriosis. Hum Reprod 20,279-285.
49. Ma X, Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K and Reynolds P (2002) Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 110,955-960.
50. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, Schmidt IM, Suomi AM, Virtanen HE et al. (2006) Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 114,270-276.
51. Makri A, Goveia M, Balbus J and Parkin R (2004) Children's susceptibility to chemicals: A review by developmental stage. J Toxicol Environ Health B Crit Rev 7,417-435.
52. Marshall LM (2002) Exposure history. In The Ontario College of Family Physicians [association website][cited 30 August 03]. Available from the internet (http://www.ocfp.on.ca/local/files/EHC/ Exposure%20Hx%20Forms.pdf).
53. Marshall L, Weir E, Abelsohn A and Sanborn MD (2002) Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ 166,1049-1055.
54. McBride W (2004) Health of thalidomide victims and their progeny. Lancet 363,169.
55. McKeever TM, Lewis SA, Smith C and Hubbard R (2002) The importance of prenatal exposures on the development of allergic disease: A birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 166,827-832.
56. McLachlan JA (2001) Environmental signaling: What embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22,319-341.
57. Meyer-Bahlburg HFL, Ehrhardt AA, Rosen LR et al. (1995) Prenatal estrogens and the development of homosexual orientation. Dev Psychol 31,12-21.
58. Miller CS and Prihoda TJ (1999) The Environmental Exposure and Sensitivity Inventory (EESI): A standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 15,370-385.
59. Miller RL, Garfinkel R, Horton M, Camann D, Perera FP, Whyatt RM and Kinney PL (2004) Polycyclic aromatic hydrocarbons, environmental tobacco smoke, and respiratory symptoms in an inner-city birth cohort. Chest 126,1071-1078.
60. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB and Hunter DJ (2004) In utero exposures and the incidence of endometriosis. Fertil Steril 82,1501-1508.
61. Mlynarcikova A, Fickova M and Scsukova S (2005) Ovarian intrafollicular processes as a target for cigarette smoke components and selected environmental reproductive disruptors. Endocr Regul 39,21-32.
62. National Research Council - Commission on Life Sciences (1999) Hormonally Active Agents in the Environment. National Academy Press, Washington, DC.
63. Needham LL, Ozkaynak H, Whyatt RM, Narr DB, Wang RY, Neaher L, Akland G, Bahadori T, Bradman A, Fortmann R et al. (2005) Exposure assessment in the national children's study: Introduction. Environ Health Perspect 113,1076-1082.
64. Osteen KG and Sierra-Rivera E (1997) Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? Semin Reprod Endocrinol 15,301-308.
65. Ott WR (1995) Human exposure assessment: The birth of a new science. J Expo Anal Environ Epidemiol 5,449-472.
66. Ozkaynak H, Whyatt RM, Needham LL, Akland G and Quakenboss J (2005) Exposure assessment implications for the design and implementation of the national children's study. Environ Health Perspect 113,1108-1115.
67. Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff C, Noller KL, Herbst AL, Rao RS, Troisi R et al. (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: Preliminary results (United States). Cancer Causes Control 13,753-758.
68. Quinn MM, Wegman DH, Greaves IA, Hammond SK, Ellenbecker MJ, Spark RF and Smith ER (1990) Investigation of reports of sexual dysfunction among male chemical workers manufacturing stilbene derivatives. Am J Ind Med 18,55-68.
69. Rapp DJ (2004) Our Toxic World: A Wake Up Call - Chemicals Damage Your Body, Brain, Behavior and Sex. Environmental Medical Research Foundation, Buffalo.
70. Rat Genome Sequencing Project Consortium (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428,493-521.
71. Rea WJ (1997) Chemical Sensitivity: (Volume 4): Tools of Diagnosis and Methods of Treatment. Lewis Publishers, Boca Raton, FL.
72. Rea WJ, Pan Y, Johnson AR et al. (1996) Reduction of chemical sensitivity by means of heat depuration, physical therapy and nutritional supplementation in a controlled environment. J Nutr Environ Med 7,141-148.
73. Rier S and Foster WG (2002) Environmental dioxins and endometriosis. Toxicol Sci 70,161-170.
74. Rier S and Foster WG (2003) Environmental dioxins and endometriosis. Semin Reprod Med 21,145-154.
75. Robbins J (2001) The Food Revolution. Conari Press, Berkeley, CA.
76. Robinson BW, Musk AW and Lake RA (2005) Malignant mesothelioma. Lancet 366,397-408.
77. Runyan CW, Johnson RM, Yang J, Waller AE, Perkis D, Marshall SW, Coyne-Beasley T and McGee KS (2005) Risk and protective factors for fires, burns, and carbon monoxide poisoning in U.S. households. Am J Prev Med 28,102-108.
78. Satoh H (2003) Behavioral teratology of mercury and its compounds. Tohoku J Exp Med 201,1-9.
79. Saunders EJ (1988) Physical and psychological problems associated with exposure to diethylstilbestrol (DES). Hosp Community Psychiatry 39,73-77.
80. Schecter A, Wallace D, Pavuk M, Piskac A and Papke O (2002) Dioxins in commercial United States baby food. J Toxicol Environ Health A 65,1937-1943.
81. Schecter A, Pavuk M, Papke O, Ryan JJ, Birnbaum L and Rosen B (2003) Polybrominated diphenyl ethers (PBDEs) in U.S. mothers' milk. Environ Health Perspect 111,1723-1729.
82. Schnare DW, Denk G, Shields M et al. (1982) Evaluation of a detoxification regimen for fat stored xenobiotics. Med Hypothesis 9,265-282.
83. Schnare DW, Ben M and Shields MG (1984) Body burden reduction of PCBs, PBBs and chlorinated pesticides in human subjects. Ambio 13,378-380.
84. Shields M, Beckman SL and Cassidy-Brinn G (1989) Improvement in perception of transcutaneous nerve stimulation following detoxification in firefighters exposed to PCBs, PCDDs and PCDFs. Clin Ecol 6,47-50.
85. Siddiqi MA, Laessig RH and Reed KD (2003) Polybrominated diphenyl ethers (PBDEs): New pollutants-old diseases. Clin Med Res 1,281-290.
86. Smith GC and Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. BMJ 327,1459-1461.
87. Sorensen HJ, Mortensen EL, Reinisch JM and Mednick SA (2003) Do hypertension and diuretic treatment in pregnancy increase the risk of schizophrenia in offspring? Am J Psychiatry 160,464-468.
88. Steele L and Fawal H (2000) 4th Decennial International Conference on nosocomial and healthcare-associated infections: A challenge for change. Am J Infect Control 28,207-210.
89. Steinhardt GF (2004) Endocrine disruption and hypospadias. Adv Exp Med Biol 545,203-215.
90. Sugiura-Ogasawara M, Ozaki Y, Sonta S et al. (2005) Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod 20,2325-2329.
91. Swan SH (2000) Intrauterine exposure to diethylstilbestrol: Long-term effects in humans. APMIS 108,793-804.
92. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, Mao CS, Redmon JB, Ternand CL, Sullivan S et al. (2005) Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113,1056-1061.
93. Tretjak Z, Shields M and Beckman SL (1990) PCB reduction and clinical improvement by detoxification: An unexploited approach. Hum Exp Toxicol 9,235-244.
94. Tsutsumi O (2005) Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 93,325-330.
95. U.S. Environmental Protection Agency Supplemental guidance for assessing susceptibility from early life exposures to carcinogens. EPA Risk Assessment Forum, EPA/630/R-03/003F, March 2005.
96. Vreugdenhil HJ, Slijper FM, Mulder PG and Weisglas-Kuperus N (2002) Effects of perinatal exposure to PCBs and dioxins on play behavior in Dutch children at school age. Environ Health Perspect 110,A593-A598.
97. Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L, Patterson D and Brambilla P (2002) Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect 110,625-628.
98. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM and Vom Saal FS (2003) Large effects from small exposures. I. Mechanisms for endocrinedisrupting chemicals with estrogenic activity. Environ Health Perspect 111,994-1006.
99. Wingspread statement on the Precautionary Principle (1998) Accessed 25 August 2005 (http://www.gdrc.org/u-gov/precaution-3.html).
100. Ziem GE and Castleman BI (1989) Threshold limit values: Historical perspectives and current practice. J Occup Med 31,910-918.